Competitors of FDC Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| MPS Pharmaa Ltd | 8.05 Cr. | 4.21 | 4.33/2.92 | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 3,605 Cr. | 331 | 390/183 | 68.4 | 20.5 | 0.20 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 60.8 Cr. | 82.0 | 94.9/27.0 | 23.3 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 37.3 Cr. | 25.5 | 27.5/8.74 | 48.4 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 84.4 Cr. | 112 | 155/87.0 | 12.6 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 12,650 Cr. | 1,030 | 1,335/666 | 29.9 | 207 | 2.18 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 408 Cr. | 18.0 | 29.0/13.2 | 23.6 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 9.01 Cr. | 18.6 | 27.1/15.0 | 180 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 351 Cr. | 748 | 1,054/650 | 19.9 | 278 | 0.09 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 64.4 Cr. | 21.5 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,182 Cr. | 402 | 440/145 | 144 | 98.6 | 0.31 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.91 Cr. | 32.9 | 43.8/23.6 | 138 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.4 Cr. | 7.80 | 19.4/7.17 | 43.2 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 236 Cr. | 295 | 307/110 | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 198 Cr. | 2.13 | 3.03/1.03 | 268 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 34.3 Cr. | 14.2 | 15.2/6.40 | 41.3 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 16.4 Cr. | 16.2 | 25.8/14.4 | 19.7 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 287 Cr. | 805 | 999/345 | 12.4 | 570 | 0.25 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 38.3 Cr. | 38.3 | 54.2/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 31.1 Cr. | 68.0 | 84.4/36.0 | 56.5 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 9.68 Cr. | 3.87 | 26.5/3.87 | 38.7 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.5 Cr. | 110 | 154/52.2 | 13.2 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.14 Cr. | 13.0 | 17.4/4.87 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 49.6 Cr. | 65.7 | 148/63.0 | 31.4 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.39 Cr. | 21.3 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 103 Cr. | 23.7 | 42.0/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 18.3 Cr. | 36.2 | 46.0/22.1 | 53.9 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 200 Cr. | 346 | 418/226 | 20.5 | 110 | 1.30 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 32.0 Cr. | 54.3 | 62.6/6.63 | 82.1 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 78,073 Cr. | 1,334 | 1,593/958 | 21.4 | 527 | 0.34 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 167 Cr. | 268 | 307/121 | 27.1 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,133 Cr. | 226 | 265/155 | 19.2 | 60.5 | 1.11 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 58.3 Cr. | 44.6 | 86.1/42.0 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,801 Cr. | 2,149 | 2,363/1,004 | 94.2 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 7.99 Cr. | 1.21 | 1.45/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 411 Cr. | 53.6 | 77.7/39.2 | 30.8 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 13.0 Cr. | 22.2 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 93.3 Cr. | 3.96 | 6.25/2.87 | 141 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 63,225 Cr. | 29,741 | 30,521/22,750 | 49.2 | 1,657 | 1.38 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,223 Cr. | 686 | 722/381 | 27.3 | 205 | 0.44 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 163 Cr. | 57.1 | 75.8/37.0 | 23.6 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,196 Cr. | 801 | 859/440 | 58.0 | 0.12 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 23,045 Cr. | 1,417 | 1,537/403 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 955 Cr. | 291 | 325/122 | 34.6 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 9.38 % | 233 % | 2.00 | |
| Venus Remedies Ltd | 425 Cr. | 318 | 430/280 | 19.2 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 5,242 Cr. | 744 | 950/416 | 105 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 1,976 Cr. | 1,408 | 1,923/1,232 | 30.5 | 735 | 0.71 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,13,633 Cr. | 3,360 | 3,591/2,270 | 65.3 | 222 | 0.83 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,417 Cr. | 264 | 317/181 | 45.6 | 44.8 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,880 Cr. | 20.0 | 27.9/11.0 | 59.2 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 29,027 Cr. | 1,139 | 1,360/585 | 120 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,782 Cr. | 128 | 169/82.1 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,53,007 Cr. | 1,886 | 1,960/1,257 | 40.4 | 288 | 0.72 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,948 Cr. | 679 | 886/322 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,018 Cr. | 239 | 398/120 | 34.4 | 70.6 | 0.17 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 355 Cr. | 1,176 | 1,750/522 | 17.4 | 621 | 0.13 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,975 Cr. | 816 | 960/313 | 139 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,418 Cr. | 176 | 241/91.8 | 208 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,066 Cr. | 6,123 | 7,600/4,606 | 33.4 | 298 | 2.73 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,625 Cr. | 2,184 | 2,977/1,319 | 41.6 | 229 | 0.73 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,703 Cr. | 5,238 | 5,850/4,637 | 38.4 | 324 | 1.15 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 249 Cr. | 70.5 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 24,079 Cr. | 5,282 | 6,453/3,950 | 39.3 | 820 | 0.66 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 245 Cr. | 199 | 348/190 | 13.4 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,565 Cr. | 419 | 491/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 9,167 Cr. | 1,807 | 1,864/702 | 77.0 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,635 Cr. | 13,724 | 18,100/5,021 | 66.8 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 874 Cr. | 39.0 | 56.5/26.2 | 81.4 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,849 Cr. | 1,387 | 1,639/805 | 12.8 | 399 | 0.68 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,283 Cr. | 78.2 | 101/38.6 | 32.6 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,464 Cr. | 297 | 359/126 | 38.9 | 50.3 | 0.20 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 183 Cr. | 115 | 145/85.2 | 19.4 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 562 Cr. | 158 | 177/97.9 | 177 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 1,07,554 Cr. | 2,356 | 2,374/1,332 | 41.0 | 343 | 0.34 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,577 Cr. | 788 | 980/498 | 16.3 | 319 | 0.23 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 32,487 Cr. | 603 | 605/359 | 138 | 79.2 | 0.13 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 899 Cr. | 867 | 961/385 | 26.1 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 199 Cr. | 93.0 | 129/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,018 Cr. | 212 | 370/198 | 19.2 | 103 | 1.42 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 525 Cr. | 326 | 470/298 | 37.4 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 17,665 Cr. | 1,105 | 1,310/532 | 62.1 | 373 | 0.45 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,589 Cr. | 1,844 | 2,030/1,474 | 46.8 | 207 | 0.66 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,623 Cr. | 611 | 820/270 | 60.6 | 74.4 | 0.82 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 42,967 Cr. | 1,695 | 1,709/1,052 | 69.0 | 264 | 0.24 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,393 Cr. | 408 | 538/331 | 23.9 | 283 | 1.23 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 180 Cr. | 33.0 | 33.1/14.3 | 3.28 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 635 Cr. | 109 | 186/86.2 | 6.21 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 3,067 Cr. | 332 | 415/286 | 138 | 118 | 0.45 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,822 Cr. | 390 | 465/260 | 65.7 | 97.6 | 0.31 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 2,040 Cr. | 2,399 | 3,379/1,293 | 86.9 | 355 | 0.25 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,561 Cr. | 455 | 504/278 | 53.7 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 14,379 Cr. | 592 | 725/382 | 29.5 | 141 | 0.25 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 45,407 Cr. | 1,609 | 1,831/767 | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 38,136 Cr. | 2,252 | 3,088/1,825 | 47.6 | 98.7 | 1.42 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 29,348 Cr. | 1,779 | 2,221/1,586 | 26.6 | 557 | 1.12 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 8,127 Cr. | 499 | 659/392 | 25.7 | 141 | 1.00 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 18,769 Cr. | 1,374 | 1,594/809 | 54.1 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,15,805 Cr. | 1,388 | 1,421/1,104 | 21.7 | 369 | 0.58 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,239 Cr. | 270 | 308/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,23,545 Cr. | 1,529 | 1,702/1,252 | 26.8 | 351 | 0.85 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 19,029 Cr. | 2,501 | 2,641/1,221 | 38.6 | 334 | 0.20 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 460 Cr. | 180 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,735 Cr. | 165 | 180/92.2 | 19.6 | 96.0 | 0.30 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 93.0 Cr. | 57.4 | 92.0/53.5 | 175 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 43,882 Cr. | 365 | 396/244 | 30.4 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,931 Cr. | 2,009 | 2,326/1,060 | 47.1 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 195 Cr. | 123 | 158/89.0 | 25.6 | 43.2 | 0.98 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 187 Cr. | 78.9 | 113/73.2 | 243 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 18,287 Cr. | 7,305 | 8,140/4,050 | 142 | 272 | 0.33 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,085 Cr. | 723 | 863/556 | 43.9 | 103 | 0.64 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 251 Cr. | 118 | 145/69.9 | 12.1 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 67,426 Cr. | 5,634 | 6,440/4,407 | 31.0 | 961 | 0.71 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,994 Cr. | 1,066 | 1,304/771 | 33.0 | 249 | 1.03 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 757 Cr. | 1,327 | 1,754/961 | 11.0 | 724 | 0.87 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 36,596 Cr. | 2,932 | 3,486/1,998 | 41.8 | 294 | 1.23 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,901 Cr. | 348 | 571/334 | 26.6 | 120 | 1.46 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,230 Cr. | 460 | 635/420 | 33.8 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,664.15 Cr | 1,198.75 | 56.43 | 184.74 | 0.31% | 16.14% | 16.48% | 6.30 |
